Advanced Therapy Medicinal Products (ATMP) Support

A developer of plasmids, lentiviral vectors, and cell-based therapies (CART/TCRT) required specialized QA support. We performed a detailed EU QP GMP audit of their ATMP manufacturing processes, followed by enhancement of their Quality Management System to address the unique challenges of gene and cell therapy production, ensuring alignment with evolving EMA guidelines.